Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
10
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 10 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Metronidazole* Metronidazole | D | $56.4M | -20% | 1,629,321 | $35 | $0.59 |
| Noritate Metronidazole | D | $3.3M | +8% | 1,090 | $2,990 | $31.90 |
| Bismuth-Metronidazole-Tetracyc Bismuth/Metronid/Tetracycline | D | $2.6M | +40% | 4,359 | $594 | $4.44 |
| Vandazole Metronidazole | D | $215K | -20% | 2,418 | $89 | $0.94 |
| Nuvessa Metronidazole | D | $130K | +18% | 439 | $295 | $40.25 |
| Metronidazole Metronidazole/Sodium Chloride | D | $64K | -13% | 1,192 | $54 | $0.02 |
| Metrogel Metronidazole | D | $40K | -73% | 60 | $671 | $5.94 |
| Metro IV* Metronidazole/Sodium Chloride* · J1836 | B | $29K | +8248% | 16,987 | $2 | $0.03 |
| Metro IV Metronidazole/Sodium Chloride | D | $2K | -50% | 25 | $72 | $0.03 |
| Flagyl Metronidazole | D | $994 | n/a | n/a | n/a | $6.45 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.